These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12973662)

  • 1. Frontal N30 of median nerve SSEPs for evaluation of movement disorders with destructive basal ganglia deficits.
    Fukuda C; Tomita Y; Maegaki Y; Kubota N
    Neuropediatrics; 2003 Aug; 34(4):205-10. PubMed ID: 12973662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic MN-SSEPs (N18, N20 and N30) might characterize underlying CNS involvements in representative types of cerebral palsy.
    Tomita Y; Fukuda C; Kato Y; Maegaki Y; Shiota S; Amisaki T
    Brain Dev; 2006 Nov; 28(10):653-9. PubMed ID: 16766152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of frontal N30 component of median nerve stimulated SSEPs in two young children with abnormal striatal lesions.
    Kato Y; Fukuda C; Maegaki Y; Inoue T; Hiraiwa R; Hiraiwa H; Ohno K; Tomita Y
    Brain Dev; 2007 May; 29(4):251-3. PubMed ID: 17049781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
    J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatosensory evoked potentials in migraine.
    de Tommaso M; Sciruicchio V; Tota P; Megna M; Guido M; Genco S; Puca F
    Funct Neurol; 1997; 12(2):77-82. PubMed ID: 9238341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
    Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
    J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
    Castillo JL; Miranda CM; Araya F; Sáez D
    Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontal SEPs and parietal SEPs following median nerve stimulation--clinical correlation and consideration of their generation sites].
    Urasaki E; Matukado Y; Wada S; Nagahiro S; Yamaguchi T; Yadomi C
    No To Shinkei; 1986 Oct; 38(10):973-80. PubMed ID: 3790362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [P22 and N30 of median nerve SSEPs--independence of the frontal waves from parietal waves].
    Fukuda C; Tomita Y; Maegaki Y
    No To Hattatsu; 2002 Jul; 34(4):295-9. PubMed ID: 12134679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of somatosensory evoked potentials in spasmodic torticollis.
    Mazzini L; Zaccala M; Balzarini C
    Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontal N30 of median nerve short latency somatosensory evoked potentials and the brain image of basal ganglia in patients with athetotic cerebral palsy].
    Ueno M; Fukuda C; Tomita Y
    No To Hattatsu; 2006 Sep; 38(5):373-4. PubMed ID: 16986740
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatosensory evoked potentials in cerebral malaria. A preliminary study.
    Kochar DK; Makkar RK
    Electromyogr Clin Neurophysiol; 1994; 34(5):301-7. PubMed ID: 7956881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological deterioration over time in patients with Huntington's disease.
    Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
    Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
    Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astereognosis and dissociated loss of frontal or parietal components of somatosensory evoked potentials in hemispheric lesions. Detailed correlations with clinical signs and computerized tomographic scanning.
    Mauguière F; Desmedt JE; Courjon J
    Brain; 1983 Jun; 106 (Pt 2)():271-311. PubMed ID: 6850271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multichannel derived median nerve SEP compared to EEG in patients with vascular cerebral lesions.
    Gardill K; Hielscher H
    Electromyogr Clin Neurophysiol; 2001 Jun; 41(4):215-23. PubMed ID: 11441639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of the basal ganglia in the generation of the N30 potential of the median nerve somatosensory evoked potentials.
    Beniczky S; Nagy H; Varga E; Vörös E; Kéri S; Vécsei L
    Ideggyogy Sz; 2007 Sep; 60(9-10):392-7. PubMed ID: 17987733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between frontal somatosensory-evoked potentials and motor planning.
    Legon W; Meehan SK; Staines WR
    Neuroreport; 2008 Jan; 19(1):87-91. PubMed ID: 18281899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial mapping of SEP in comatose patients: improved outcome prediction by combined parietal N20 and frontal N30 analysis.
    Facco E; Munari M; Donà B; Baratto F; Fiore D; Behr AU; Giron G
    Brain Topogr; 1991; 3(4):447-55. PubMed ID: 1742161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients.
    Insola A; Mazzone P; Valeriani M
    Muscle Nerve; 2005 Dec; 32(6):791-7. PubMed ID: 16124001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.